Home Cart Sign in  
Chemical Structure| 23666-13-9 Chemical Structure| 23666-13-9

Structure of Vicenin 2
CAS No.: 23666-13-9

Chemical Structure| 23666-13-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Vicenin 2 is a flavonoid-type angiotensin-converting enzyme (ACE) inhibitor (IC50=43.83 μM) that exhibits a wide range of biological activities, including radiation protection, antioxidant effects, anti-glycation, and anti-cancer properties, valuable in related disease research.

Synonyms: Vicenin II; Violantin; Apigenin-6,8-di-C-glycoside

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Vicenin 2

CAS No. :23666-13-9
Formula : C27H30O15
M.W : 594.52
SMILES Code : O=C1C=C(C2=CC=C(O)C=C2)OC3=C1C(O)=C([C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)C(O)=C3[C@H]5[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O5
Synonyms :
Vicenin II; Violantin; Apigenin-6,8-di-C-glycoside
MDL No. :MFCD08458851

Safety of Vicenin 2

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HT-29 human colon cancer cells 0, 3.12, 6.24, 12.5, 25, 50, 100, 150 µM 24 and 48 hours To evaluate the effect of Vicenin-2 on the viability of HT-29 cells, results showed that Vicenin-2 decreased cell viability in a concentration- and time-dependent manner with an IC50 value of 50 µM Drug Des Devel Ther. 2018 May 18;12:1303-1310
MCF-7 breast cancer cells 199.1 µM 24 hours Evaluate the effect of vicenin-2 on MCF-7 cell viability, showing an IC50 of 199.1 µM Nutrients. 2022 Feb 13;14(4):784
DU-145 cells 50 µM 24 hours VCN-2 effectively induced anti-proliferative, pro-apoptotic effects, inhibited EGFR/Akt/mTOR/p70S6K pathway, and decreased levels of c-Myc, cyclin D1, cyclin B1, CDK4, PCNA, and hTERT Biochem Pharmacol. 2011 Nov 1;82(9):1100-9
PC-3 cells 50 µM 24 hours VCN-2 effectively induced anti-proliferative, pro-apoptotic effects, inhibited EGFR/Akt/mTOR/p70S6K pathway, and decreased levels of c-Myc, cyclin D1, cyclin B1, CDK4, PCNA, and hTERT Biochem Pharmacol. 2011 Nov 1;82(9):1100-9
LNCaP cells 50 µM 24 hours VCN-2 effectively induced anti-proliferative, pro-apoptotic effects, inhibited EGFR/Akt/mTOR/p70S6K pathway, and decreased levels of c-Myc, cyclin D1, cyclin B1, CDK4, PCNA, and hTERT Biochem Pharmacol. 2011 Nov 1;82(9):1100-9
THP-1 cells 12.5–200 µM 24 hours Assess the safety of vicenin-2, results showed no cytotoxicity within 24 hours Int J Mol Sci. 2025 Feb 27;26(5):2077
RAW 264.7 cells up to 100 µM 24 hours To evaluate the cytotoxic effect of Vicenin-2 on RAW 264.7 cells, results showed no significant cytotoxicity up to 100 µM concentration. Life (Basel). 2023 Nov 30;13(12):2289
Caco-2 cells 75 µM and 100 µM 24 hours To evaluate the cytotoxic effect of Vicenin-2 on Caco-2 cells, results showed significant reduction in cell viability at 75 µM and 100 µM concentrations. Life (Basel). 2023 Nov 30;13(12):2289
THP-1 cells 100 and 200 µM 3 hours Evaluate the effect of vicenin-2 on SIRT1 expression and activity, results showed vicenin-2 restored SIRT1 expression and activity Int J Mol Sci. 2025 Feb 27;26(5):2077
THP-1 cells 100 and 200 µM 3 hours Assess the effect of vicenin-2 on iNOS and COX-2 mRNA expression, results showed vicenin-2 significantly reduced mRNA levels of both enzymes Int J Mol Sci. 2025 Feb 27;26(5):2077
THP-1 cells 100 and 200 µM 3 hours Evaluate the anti-inflammatory effect of vicenin-2 on LPS-induced inflammatory response, results showed vicenin-2 significantly reduced mRNA levels and secretion of TNF-α, IL-1β, and IL-6 Int J Mol Sci. 2025 Feb 27;26(5):2077
Human serum albumin (HSA) 0.1–25.0 µM 6 hours Vicenin-2 effectively prevented heat-induced fibrillation and aggregation of HSA. Int J Mol Sci. 2023 Dec 7;24(24):17222

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice PC3 prostate cancer xenograft model Oral gavage 1 mg/kg Alternate day administration for 60 days VCN-2 alone or in combination with docetaxel significantly inhibited prostate tumor growth, decreased levels of AR, pIGF1R, pAkt, PCNA, cyclin D1, Ki67, CD31, and increased E-cadherin expression Biochem Pharmacol. 2011 Nov 1;82(9):1100-9
Male C57BL/6J mice Paclitaxel-induced neuropathic pain model Intraperitoneal injection 10 mg/kg Administered between D10 and D21 To evaluate the antinociceptive effect of Vicenin-2 on paclitaxel-induced neuropathic pain, results showed significant alleviation of cold and mechanical allodynia at 10 mg/kg dose. Life (Basel). 2023 Nov 30;13(12):2289

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.68mL

0.34mL

0.17mL

8.41mL

1.68mL

0.84mL

16.82mL

3.36mL

1.68mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories